SBIR/STTR awards granted by Food and Drug Administration | 34 results

where

Government Branch

Food and Drug Administration

Save querySave query

Access by APIAccess by API

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ CFD Research Corporation SBIR Phase II Award, September 2019	A SBIR Phase II contract was awarded to CFD Research Corporation in September, 2019 for $999,921.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	CFD Research Corporation	Food and Drug Administration	SBIR	2R44FD005345-02	Phase II	999,921	September 1, 2019	sbir.gov/node/1682581
‌ CFD Research Corporation SBIR Phase I Award, September 2020	A SBIR Phase I contract was awarded to CFD Research Corporation in September, 2020 for $168,085.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	CFD Research Corporation	Food and Drug Administration	SBIR	1R43FD006979-01	Phase I	168,085	September 1, 2020	sbir.gov/node/1917109
‌ Lookin, Inc. SBIR Phase I Award, September 2019	A SBIR Phase I contract was awarded to Lookin, Inc. in September, 2019 for $150,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Lookin, Inc.	Food and Drug Administration	SBIR	1R43FD006703-01	Phase I	150,000	September 1, 2019	sbir.gov/node/1685555
‌ Venarum Medical, LLC SBIR Phase I Award, September 2020	A SBIR Phase I contract was awarded to VENARUM MEDICAL, LLC in September, 2020 for $167,648.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	‌ VENARUM MEDICAL, LLC	Food and Drug Administration	SBIR	1R43FD006891-01A1	Phase I	167,648	September 1, 2020	sbir.gov/node/1914823
‌ En Solucion Inc SBIR Phase II Award, September 2020	A SBIR Phase II contract was awarded to En Solucion Inc in September, 2020 for $1,120,586.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	En Solucion Inc	Food and Drug Administration	SBIR	2R44FD006465-02	Phase II	1,120,586	September 1, 2020	sbir.gov/node/1911593
‌ FUNCTIONAL FLUIDICS INC. SBIR Phase I Award, September 2020	A SBIR Phase I contract was awarded to Functional Fluidics in September, 2020 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Functional Fluidics	Food and Drug Administration	SBIR	1R43FD006939-01	Phase I	168,087	September 1, 2020	sbir.gov/node/1916339
‌ VisuGen Global, LLC SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to VisuGen Global, LLC in September, 2018 for $149,998.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	‌ VisuGen Global, LLC	Food and Drug Administration	SBIR	1R43FD006462-01	Phase I	149,998	September 1, 2018	sbir.gov/node/1571589
‌ TRUMEDICINES LLC SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to TruMedicines in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	TruMedicines	Food and Drug Administration	SBIR	1R43FD006302-01	Phase I	225,000	September 1, 2018	sbir.gov/node/1573631
‌ Trace-Ability, Inc. SBIR Phase I Award, September 2021	A SBIR Phase I contract was awarded to Trace-Ability, Inc. in September, 2021 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Trace-Ability, Inc.	Food and Drug Administration	SBIR	1R43FD006914-01A1	Phase I	168,087	September 20, 2021	sbir.gov/node/2188413
‌ NANOHMICS INC SBIR Phase I Award, September 2020	A SBIR Phase I contract was awarded to Nanohmics in September, 2020 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Nanohmics	Food and Drug Administration	SBIR	1R43FD006910-01	Phase I	168,087	September 1, 2020	sbir.gov/node/1915133
‌ MOCKV SOLUTIONS INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to MOCKV SOLUTIONS INC. in September, 2018 for $150,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	‌ MOCKV SOLUTIONS INC.	Food and Drug Administration	SBIR	1R43FD006472-01	Phase I	150,000	September 1, 2018	sbir.gov/node/1571851
‌ Apricity Therapeutics SBIR Phase I Award, September 2020	A SBIR Phase I contract was awarded to Apricity Therapeutics in September, 2020 for $168,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	‌ Apricity Therapeutics	Food and Drug Administration	SBIR	1R43FD006909-01	Phase I	168,000	September 1, 2020	sbir.gov/node/1914567
‌ En Solucion Inc SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to En Solucion Inc in September, 2018 for $150,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	En Solucion Inc	Food and Drug Administration	SBIR	1R43FD006465-01	Phase I	150,000	September 1, 2018	sbir.gov/node/1571865
‌ NANOHMICS INC SBIR Phase II Award, September 2022	A SBIR Phase II contract was awarded to Nanohmics in September, 2022 for $585,293.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Nanohmics	Food and Drug Administration	SBIR	2R44FD006910-02	Phase II	585,293	September 20, 2022	sbir.gov/node/2341747
‌ Venarum Medical, LLC SBIR Phase II Award, September 2022	A SBIR Phase II contract was awarded to VENARUM MEDICAL, LLC in September, 2022 for $831,482.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	‌ VENARUM MEDICAL, LLC	Food and Drug Administration	SBIR	2R44FD006891-02A1	Phase II	831,482	September 20, 2022	sbir.gov/node/2339549
‌ Applied BioMath, LLC SBIR Phase I Award, September 2019	A SBIR Phase I contract was awarded to Applied Biomath in September, 2019 for $150,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Applied BioMath	Food and Drug Administration	SBIR	1R43FD006606-01	Phase I	150,000	September 1, 2019	sbir.gov/node/1689669
‌ RPRD Diagnostics, LLC SBIR Phase I Award, September 2020	A SBIR Phase I contract was awarded to RPRD Diagnostics in September, 2020 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	RPRD Diagnostics	Food and Drug Administration	SBIR	1R43FD007247-01A1	Phase I	168,087	September 15, 2020	sbir.gov/node/1917687
‌ AKONNI BIOSYSTEMS INC. SBIR Phase I Award, September 2021	A SBIR Phase I contract was awarded to Akonni Biosystems in September, 2021 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Akonni Biosystems	Food and Drug Administration	SBIR	1R43FD007315-01	Phase I	168,087	September 20, 2021	sbir.gov/node/2189629
‌ TRIPLE RING TECHNOLOGIES, INC. SBIR Phase I Award, September 2021	A SBIR Phase I contract was awarded to Triple Ring Technologies in September, 2021 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Triple Ring Technologies	Food and Drug Administration	SBIR	1R43FD007313-01	Phase I	168,087	September 20, 2021	sbir.gov/node/2189641
‌ En Solucion Inc SBIR Phase I Award, September 2022	A SBIR Phase I contract was awarded to En Solucion Inc in September, 2022 for $259,610.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	En Solucion Inc	Food and Drug Administration	SBIR	1R43FD007703-01	Phase I	259,610	September 20, 2022	sbir.gov/node/2342091
‌ MIDI, INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to MIDI in September, 2018 for $148,641.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	MIDI	Food and Drug Administration	SBIR	1R43FD006301-01	Phase I	148,641	September 1, 2018	sbir.gov/node/1573925
‌ NANOHMICS INC SBIR Phase I Award, September 2022	A SBIR Phase I contract was awarded to Nanohmics in September, 2022 for $259,613.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Nanohmics	Food and Drug Administration	SBIR	1R43FD007587-01	Phase I	259,613	September 20, 2022	sbir.gov/node/2340797
‌ THERAFLUOR, INC. SBIR Phase I Award, September 2022	A SBIR Phase I contract was awarded to THERAFLUOR, INC. in September, 2022 for $259,613.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	‌ THERAFLUOR, INC.	Food and Drug Administration	SBIR	1R43FD007525-01	Phase I	259,613	September 20, 2022	sbir.gov/node/2339593
‌ TRIPLE RING TECHNOLOGIES INC SBIR Phase I Award, September 2022	A SBIR Phase I contract was awarded to Triple Ring Technologies in September, 2022 for $198,918.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	Triple Ring Technologies	Food and Drug Administration	SBIR	1R43FD007584-01	Phase I	198,918	September 27, 2022	sbir.gov/node/2340485
‌ Apricity Therapeutics SBIR Phase I Award, September 2022	A SBIR Phase I contract was awarded to Apricity Therapeutics in September, 2022 for $168,400.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.	‌ Apricity Therapeutics	Food and Drug Administration	SBIR	1R43FD007586-01	Phase I	168,400	September 20, 2022	sbir.gov/node/2340063

SBIR/STTR Award Recipient

Contract Number (US Government)

A SBIR Phase II contract was awarded to CFD Research Corporation in September, 2019 for $999,921.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to CFD Research Corporation in September, 2020 for $168,085.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Lookin, Inc. in September, 2019 for $150,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to VENARUM MEDICAL, LLC in September, 2020 for $167,648.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase II contract was awarded to En Solucion Inc in September, 2020 for $1,120,586.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Functional Fluidics in September, 2020 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to VisuGen Global, LLC in September, 2018 for $149,998.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to TruMedicines in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Trace-Ability, Inc. in September, 2021 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Nanohmics in September, 2020 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to MOCKV SOLUTIONS INC. in September, 2018 for $150,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Apricity Therapeutics in September, 2020 for $168,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to En Solucion Inc in September, 2018 for $150,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase II contract was awarded to Nanohmics in September, 2022 for $585,293.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase II contract was awarded to VENARUM MEDICAL, LLC in September, 2022 for $831,482.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Applied Biomath in September, 2019 for $150,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to RPRD Diagnostics in September, 2020 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Akonni Biosystems in September, 2021 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Triple Ring Technologies in September, 2021 for $168,087.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to En Solucion Inc in September, 2022 for $259,610.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to MIDI in September, 2018 for $148,641.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Nanohmics in September, 2022 for $259,613.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to THERAFLUOR, INC. in September, 2022 for $259,613.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Triple Ring Technologies in September, 2022 for $198,918.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

A SBIR Phase I contract was awarded to Apricity Therapeutics in September, 2022 for $168,400.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration.

34 results

0 selected

34 results

0 selected